Cerus
CERS
#7689
Rank
NZ$0.62 B
Marketcap
NZ$3.26
Share price
-9.18%
Change (1 day)
6.22%
Change (1 year)

Cerus (CERS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.26 Billion

According to Cerus's latest financial reports the company's total liabilities are NZ$0.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cerus - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.25 B11.91%
2023-12-31NZ$0.22 B-3.11%
2022-12-31NZ$0.23 B5.92%
2021-12-31NZ$0.22 B36.42%
2020-12-31NZ$0.16 B1.19%
2019-12-31NZ$0.16 B36.87%
2018-12-31NZ$0.11 B40.94%
2017-12-31NZ$83.5 M26.6%
2016-12-31NZ$65.95 M1.13%
2015-12-31NZ$65.21 M26.94%
2014-12-31NZ$51.37 M4.03%
2013-12-31NZ$49.38 M36.29%
2012-12-31NZ$36.23 M4.54%
2011-12-31NZ$34.66 M9.45%
2010-12-31NZ$31.67 M76.37%
2009-12-31NZ$17.95 M-20.21%
2008-12-31NZ$22.5 M-5.91%
2007-12-31NZ$23.91 M13.51%
2006-12-31NZ$21.07 M-38.41%
2005-12-31NZ$34.21 M-69.71%
2004-12-31NZ$0.11 B11.35%
2003-12-31NZ$0.10 B216.39%
2002-12-31NZ$32.05 M-38.1%
2001-12-31NZ$51.78 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Haemonetics
HAE
NZ$2.75 B 941.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$4.5 M-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$33.04 B 12,370.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
NZ$5.66 M-97.86%๐Ÿ‡บ๐Ÿ‡ธ USA